Abstract: Disclosed are a polyethylene glycol conjugate drug, and a preparation method therefor and the use thereof. Specifically, the present invention relates to a polyethylene glycol conjugate drug represented by formula A or a pharmaceutically acceptable salt thereof, a method for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, an intermediate for preparing the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof, and the use of the polyethylene glycol conjugate drug or the pharmaceutically acceptable salt thereof in the preparation of a drug.

Abstract: A series of piperidine-substituted benzoic acid compounds and the use thereof, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: Provided are a method and apparatus for evaluating a degree of frequency regulation urgency of a generator set, a power system and a storage medium.

Abstract: The present disclosure provides a magnetic dressing and a preparation method and use thereof, belonging to the technical field of pharmaceutical preparations. The magnetic dressing includes a magnetic layer, a drug-loading layer, and a protective layer that are stacked in sequence, where the magnetic layer includes polyvinyl alcohol, gluten, and iron particles. In the present disclosure, a swallowed magnetic dressing is controlled by an external magnetic field, and the magnetic dressing is moved to a pathological position by changing a direction of the external magnetic field; after the external magnetic field is removed, the magnetic dressing changes from a ring to a sheet, thereby completing attachment of an entire lesion surface to complete treatment by autonomous drug release.

Abstract: Techniques are disclosed relating to the management of data. A data provider computer system may store particular data of a user. The data provider computer system may commence sharing of a portion of the particular data with a data consumer computer system. The data provider computer system may continue sharing additional portions of the particular data with the data consumer computer system in response to receiving a report from a verification environment indicating that the particular data is being utilized by the data consumer computer system in accordance with a specified usage policy.

Abstract: The present invention relates to a crystal form and a salt of a compound serving as a Pan-HER tyrosine kinase inhibitor and a preparation method therefor, and also use thereof in the preparation of a medicament for treating solid tumors.

Abstract: Techniques are disclosed relating to data management. A computer system may evaluate network traffic to extract and group data objects based on their content satisfying similarity criteria, and to identify baseline behavior with respect to those data objects. The computer system may generate data-defined network (DDN) data structures that include a content class and one or more behavioral classes. The content class may be indicative of one or more of the data objects that have been grouped based on them satisfying the similarity criteria. The one or more behavioral classes may indicate baseline behavior of those data objects within the content class as determined from evaluation of the network traffic. The computer system may detect, using the DDN data structures, anomalous data behavior within network traffic. In response to detecting anomalous data behavior, the computer system may prevent network traffic corresponding to the anomalous data behavior from being communicated.

Abstract: Provided are a method and apparatus for evaluating a degree of frequency regulation urgency of a generator set, a power system and a storage medium.

Abstract: The present invention relates to a series of quinazoline compounds, especially compounds as represented by formula (I), isomers thereof or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and use thereof as Pan-HER tyrosine kinase inhibitors.

Abstract: Techniques are disclosed relating to data management. A computer system may evaluate network traffic to extract and group data objects based on their content satisfying similarity criteria, and to identify baseline behavior with respect to those data objects. The computer system may generate data-defined network (DDN) data structures that include a content class and one or more behavioral classes. The content class may be indicative of one or more of the data objects that have been grouped based on them satisfying the similarity criteria. The one or more behavioral classes may indicate baseline behavior of those data objects within the content class as determined from evaluation of the network traffic. The computer system may detect, using the DDN data structures, anomalous data behavior within network traffic. In response to detecting anomalous data behavior, the computer system may prevent network traffic corresponding to the anomalous data behavior from being communicated.

Abstract: Techniques are disclosed relating to the management of data. A data provider computer system may store particular data of a user. The data provider computer system may commence sharing of a portion of the particular data with a data consumer computer system. The data provider computer system may continue sharing additional portions of the particular data with the data consumer computer system in response to receiving a report from a verification environment indicating that the particular data is being utilized by the data consumer computer system in accordance with a specified usage policy.